peter_maag

Carsten Schroeder appointed interim president of Novartis Diagnostics

pharmafile | October 31, 2011 | Appointment | Sales and Marketing Novartis 

Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa.

He will now take over at the firm’s diagnostics site in Emeryville, California.

Schroeder will replace Peter Maag, who was president and global head of Novartis Diagnostics for two years before leaving the firm last month, until a permanent president is found. 

Advertisement

Maag had worked for the Swiss firm in various positions for 10 years, including president of Novartis Germany.

Related Content

Novartis receives SMC approval for early breast cancer treatment

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval …

drug-trials

Novartis candidate for Sjögren’s disease presents positive results

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 …

Mosquito image

First malaria medicine for infants under 4.5kg receives approval

Coartem (artemether-lumefantrine) Baby, or Riamet, has been approved by Swissmedic as the first malaria medicine …

The Gateway to Local Adoption Series

Latest content